Skip To The Main Content
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
 
Peter Guryan
Partner
 
425 Lexington Avenue
New York, NY 10017 
 
Email:
Phone: +1-212-455-2750
Fax: +1-212-455-2502
Peter Guryan is a leading antitrust lawyer with extensive experience in civil and criminal antitrust matters for major corporations and private equity firms. He has represented clients in obtaining antitrust approvals in numerous high-profile and challenging transactions, often global in scope, and in other government antitrust investigations before the Department of Justice, the Federal Trade Commission and competition authorities outside of the United States. Prior to joining private practice, Peter was a trial attorney in the Antitrust Division of the Department of Justice.

Read Full Biography...

Work Highlights
  • Gerdau S.A. in connection with its sale of certain U.S. steel operations to Commercial Metals Company
  • Private equity firms KKR, Blackstone, BCP and their respective portfolio companies, as antitrust counsel, in a variety of transactions, including: Air Medical Group; BMC Software; Envision Healthcare; MB Aerospace; Thomson Reuters’ Financial & Risk Business; and PharMerica
  • ChemChina in securing antitrust clearance for its $43 billion acquisition of Swiss agrochemical company Syngenta AG
  • Global Medical Response (formerly AMGH) in connection with its $2.4 billion acquisition of AMR from Envision Healthcare Corporation
  • Secured a dismissal of all claims for Tradeweb Markets in an antitrust class action alleging several financial institutions and trading platforms conspired to limit competition in the $320 trillion market for interest rate swaps
  • Avantor Inc. in connection with its $6.4 billion acquisition of VWR Corporation 
  • NXP Semiconductors N.V. in connection with its $11.8 billion acquisition of Freescale Semiconductor, Ltd.
  • Ingersoll-Rand in the acquisition of the centrifugal compression division of Cameron International Corporation
  • Owens-Illinois, Inc. in connection with its $2.15 billion acquisition of Vitro, S.A.B. de C.V.
Accolades
  • Chambers USA: America's Leading Lawyers for Business
  • The Legal 500 United States
Education
  • Cornell Law School, 1996 J.D.
    cum laude
  • Cornell University, 1992 B.A.
Clerkships
  • Hon. Harold A. Ackerman, U.S. District Court for the District of New Jersey (1996-1998)
Admissions
  • U.S. District Court for the Southern District of New York 
  • New York 1998

Peter Guryan is a Partner resident in the Firm’s New York office and a member of the Firm’s Antitrust Practice.  Peter has extensive experience in civil and criminal antitrust matters for major corporations and private equity firms.  He has represented clients in obtaining antitrust approvals in numerous high-profile and challenging transactions, often global in scope, and in other government antitrust investigations before the Department of Justice, the Federal Trade Commission and competition authorities outside of the United States. 

Peter’s recent work highlights include:

  • Avantor Inc. in connection with its $6.4 billion acquisition of VWR Corporation;
  • Blackstone and related portfolio companies, as antitrust counsel, in a variety of transactions, including: MB Aerospace; PSAV; and Thomson Reuters’ Financial & Risk Business;
  • ChemChina in securing antitrust clearance for its $43 billion acquisition of Swiss agrochemical company Syngenta AG;
  • Gerdau S.A. in connection with its sale of certain U.S. steel operations to Commercial Metals Company;
  • Global Medical Response (formerly AMGH) in connection with its $2.4 billion acquisition of AMR from Envision Healthcare Corporation;
  • Ingersoll-Rand in the acquisition of the centrifugal compression division of Cameron International Corporation;
  • KKR and related portfolio companies, as antitrust counsel, in a variety of transactions, including: BMC Software; Envision Healthcare; and PharMerica;
  • NXP Semiconductors N.V. in connection with its $11.8 billion acquisition of Freescale Semiconductor, Ltd.;
  • Owens-Illinois, Inc. in connection with its $2.15 billion acquisition of Vitro, S.A.B. de C.V.; and
  • Tradeweb Markets in an antitrust class action alleging several financial institutions and trading platforms conspired to limit competition in the $320 trillion market for interest rate swaps; secured a dismissal of all claims.

Prior to joining Simpson Thacher, Peter was a partner at Fried Frank.  He began his career at the Antitrust Division of the Department of Justice where he played a significant role in the successful challenge of the proposed merger between WorldCom and Sprint. In addition, he was a law clerk to the Honorable Harold A. Ackerman on the United States District Court for the District of New Jersey.

Peter is consistently recognized by Chambers USA: America's Leading Lawyers for Business as a leading individual in Antitrust and by Legal 500 in Mergers, Acquisitions and Buyouts: Antitrust.

Peter is admitted to the bar in New York and to practice before the United States District Court for the Southern District of New York. He received his J.D., cum laude, in 1996 from Cornell Law School and his B.A. in 1992 from Cornell University. 

News & Events

    Publications